Synapse

← Mark A. Creager

Papers by Mark A. Creager

Page 2 · newest first

  1. Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and HaemostasisResearch and Practice in Thrombosis and Haemostasis · 2020
  2. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery DiseaseArteriosclerosis Thrombosis and Vascular Biology · 2020
  3. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart AssociationCirculation · 2020
  4. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trialVascular Medicine · 2020
  5. Implementation of Supervised Exercise Therapy for Patients With Symptomatic Peripheral Artery Disease: A Science Advisory From the American Heart AssociationCirculation · 2019
  6. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery DiseaseJAMA · 2018
  7. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisCirculation · 2017
  8. American Heart Association’s Call to Action for Payment and Delivery System ReformCirculation · 2017
  9. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart AssociationCirculation · 2017
  10. Alternative causes of myocardial ischemia in women: An update on spontaneous coronary artery dissection, vasospastic angina and coronary microvascular dysfunctionVascular Medicine · 2017
  11. Pathophysiology of Intermittent Claudication in Peripheral Artery DiseaseCirculation Journal · 2017
  12. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart AssociationCirculation · 2016
  13. Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trialAJP Heart and Circulatory Physiology · 2016
  14. Resolvin D2 Enhances Postischemic Revascularization While Resolving InflammationCirculation · 2016
  15. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) TrialJournal of the American Heart Association · 2016
  16. Vascular Complications of DiabetesCirculation Research · 2016
  17. Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy PortfolioCirculation · 2016
  18. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery DiseaseCirculation · 2016
  19. Surgery for Aortic Dilatation in Patients With Bicuspid Aortic ValvesCirculation · 2015
  20. Pharmacological Treatment and Current Management of Peripheral Artery DiseaseCirculation Research · 2015
  21. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndromeVascular Medicine · 2015
  22. The Society for Vascular Medicine: The first quarter centuryVascular Medicine · 2015
  23. The first 10 years of the American Board of Vascular MedicineVascular Medicine · 2014
  24. Guidelines for the Primary Prevention of StrokeStroke · 2014
  25. Socioeconomic Inequality and Peripheral Artery Disease Prevalence in US AdultsCirculation Cardiovascular Quality and Outcomes · 2014
  26. An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2014
  27. Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139Diabetes Care · 2014
  28. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)Diabetes Care · 2013
  29. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal · 2013
  30. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IIEuropean Heart Journal · 2013
  31. Vorapaxar in Patients With Peripheral Artery DiseaseCirculation · 2013
  32. Measurement and Interpretation of the Ankle-Brachial IndexCirculation · 2012
  33. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalitiesJournal of Thoracic and Cardiovascular Surgery · 2012
  34. The Assessment of Endothelial FunctionCirculation · 2012
  35. Acute Limb IschemiaNew England Journal of Medicine · 2012
  36. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyEuropean Heart Journal · 2012
  37. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summaryJournal of Thoracic and Cardiovascular Surgery · 2011
  38. The Creating an Optimal Warfarin Nomogram (CROWN) StudyThrombosis and Haemostasis · 2011
  39. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathyJournal of Thoracic and Cardiovascular Surgery · 2011
  40. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summaryJournal of Thoracic and Cardiovascular Surgery · 2011
  41. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateCirculation · 2011
  42. High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in WomenCirculation · 2011
  43. Effect of Hypoxia-Inducible Factor-1α Gene Therapy on Walking Performance in Patients With Intermittent ClaudicationCirculation · 2011
  44. Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucoseClinical Science · 2011
  45. TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow–derived proangiogenic cell differentiation, function, and neovascularizationBlood · 2011
  46. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in womenVascular Medicine · 2011
  47. Secondary Prevention and Mortality in Peripheral Artery DiseaseCirculation · 2011
  48. Smoking, Smoking Cessation, and Risk for Symptomatic Peripheral Artery Disease in WomenAnnals of Internal Medicine · 2011
  49. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summaryJournal of NeuroInterventional Surgery · 2011
  50. Effect of Propionyl-L-carnitine on a Background of Monitored Exercise in Patients With Claudication Secondary to Peripheral Artery DiseaseJournal of Cardiopulmonary Rehabilitation and Prevention · 2011